Skip To Main Content
Thomas VanCott on Muck Rack

Thomas VanCott

As seen in: Bioprocess Online, Cell & Gene Therapy Insights, Outsourced Pharma, Cell & Gene
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Thomas VanCott’s profile

Articles by Thomas VanCott

Accelerating your gene therapy to patients: not all platforms are created equal

|
By George Buchman, Catalent Cell, Thomas VanCott
| Cell & Gene Therapy Insights Verified
Thursday June 22nd 2023 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format. The field of gene therapy manufacturing faces a significant hurdle in the form of a lack of process standardization. There are ways to address this challenge, however, such as using standardized methods, materials, analytics, and documentation.
Open in Who Shared Issue with article?

12.21.22 -- New Year For Novo Nordisk's Wegovy Supply Challenges

|
By Louis Garguilo Verified, Patrick Middag, Thomas VanCott, David Butcher
| Outsourced Pharma
By Patrick Middag and Dennie van de Voort, Deloitte Major regulators including the FDA and EMA have established frameworks through which data must be captured and exchanged with them. But your pharma, biotech, or medical device company needs a solid plan for how the data will be governed.
Open in Who Shared Issue with article?

06.23.22 -- How to Use RWE for Access to CGTs

|
By Youbean Oak, Zachary Kleiman, Samantha Cambray, Thomas VanCott
| Cell & Gene Verified
Article | By Thomas VanCott, Ph.D., Catalent The success of using viral vectors to deliver a molecular payload into a cell or replace defective genes with functional ones is an inflection point in the future of modern medicine. Article | By Stephany Cook, Kymanox Corporation Examine how RMM differs from traditional microbiologic methods that rely on lengthy incubation periods and understand why there is a shift favoring RMM for pharmaceutical manufacturing.
Open in Who Shared Issue with article?

06.15.22 -- AstraZeneca Implements A "Technology Uplift" Of Its Microbiology Labs

|
By Miriam Guest, Matthew Pillar Verified, Thomas VanCott
| Bioprocess Online Verified
By Miriam Guest, AstraZeneca Modern microbiology labs are busy, with a wide range of activities taking place from final product testing to auxiliary support such as quality control release checks on nutrient media. While instruments and equipment available to technicians can vary, AstraZeneca wanted a networkwide approach to modernizing its labs.
Open in Who Shared Issue with article?
Show More